News Search

Tag: Novartis

Five Years of Data Show Long-term Promise for Penn and Novartis’ Car-T Pioneer Kymriah

June 17, 2022 | Posted in Corporate Alliances, Penn in the News, School of Medicine

Five years after Penn and Novartis made history with the FDA approval of Kymriah, a recent study shows the long-term impact of the medication on patient remission rates. 

Filter

Skip to content